Septin5通过GFPT1调控甘露糖代谢重编程在肾透明细胞癌中的功能及分子机制研究
批准号:
82103388
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
杨哲
依托单位:
学科分类:
肿瘤代谢
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
杨哲
中文摘要
肾透明细胞癌(ccRCC)进展迅速、预后不良、治疗特异性差,原因在于其发生发展机制仍未被阐明。因此,揭示其特异性分子机制是ccRCC研究的关键。前期研究发现,ccRCC中存在甘露糖摄入和代谢异常,同时,在肿瘤中通过相互作用和异常表达发挥功能的Septin家族因子Septin5也出现高表达。本项目将明确ccRCC中是否存在甘露糖代谢重编程,及其与ccRCC发生发展的相关性。其次,确定Septin5是否与甘露糖代谢的重要过程己糖胺生物合成途径的关键酶GFPT1相互作用而抑制其活性,进而降低P53糖基化及其稳定性,同时改变通过底物正向调节作用促进糖酵解,为ccRCC细胞提供更多物质和能量来源。通过上述机制,甘露糖代谢发生重编程并促进ccRCC发生发展。本项目从多组学分析代谢重编程出发,是基因表达产物与代谢调节相结合的研究新视角,其顺利完成将为ccRCC诊疗发展提供新线索。
英文摘要
Clear cell renal cell carcinoma (ccRCC) has the characteristics of rapid progress, poor prognosis rate and lack of specific therapy which is caused by unclear mechanism of tumorigenesis and development. Therefore, understanding the mechanism of ccRCC tumorigenesis and development and revealing its specific characteristics are the key for ccRCC research. In the preliminary research, intake and metabolic reprogramming of mannose can be found in ccRCC. While Septin5, a member of Septin family which always excute oncological function via abnomal expression and interaction, is also observed in ccRCC. In the present study, it will be verified that whether mannose metabolism is reprogrammed in ccRCC and the correlation between mannose metabolic reprogramming and ccRCC tumorigenesis and development will also be unraveled. Subsequently, the underlying mechanism will be demonstrated that Septin5, inhibits GFPT1 activity, which is the key enzyme of hexosamine biosynthesis pathway, a critical mannose metabolic pathway, by interacting with it to decline P53 GlcNacylation, and finally reduces P53 protein stability. Meanwhile, this process will change mannose metabolic flux, promotes glycolysis via substrate positive regulatory effect, and finally provide more materials and energy for ccRCC cells. Mannose metabolic reprogramming will promote ccRCC tumorigenesis and development based on the above mechanisms. Taken together, this study starts from investigation of metabolic reprogramming by multi-omics analysis, which is a new perspective for the integrated research of gene expression products and metabolites. The results and achievements of this study will provide new clues for the precise diagnosis and treatment of ccRCC.
肾透明细胞癌(ccRCC)是泌尿系统恶性肿瘤,代谢重编程在ccRCC发展中起关键作用。本项目探讨甘露糖代谢异常在ccRCC发病机制中的作用,旨在为ccRCC的诊疗提供新思路。.通过一系列研究,本项目发现Septin5可能是ccRCC甘露糖代谢异常关键因子,其机制涉及糖酵解途径和HBP途径。检测GFAT1酶活性、UDP-GlcNAc含量、蛋白质O-糖基化水平、PFK表达和酶活性、L-乳酸含量。使用Seahorse XF代谢检测系统检测糖酵解速率。通过免疫共沉淀法检测Septin5与GFAT1的相互作用。检测SEPT5敲低/过表达的ccRCC细胞系中p53蛋白表达及O-糖基化水平。在小鼠体内进行皮下种植瘤实验,探究甘露糖对SEPT5敲低和过表达的ccRCC细胞株的影响。检测结果表明,甘露糖代谢相关物质和催化酶在ccRCC及癌旁组织中存在显著差异,提示甘露糖代谢重编程可能是ccRCC特异性代谢通路。体外实验显示,甘露糖可改变ccRCC细胞增殖水平,提示其与ccRCC发生发展有关。Septin5在ccRCC中高表达,促进细胞增殖和侵袭迁移。Septin5通过与GFAT1相互作用抑制HBP途径,降低UDP-GlcNAc含量,促进糖酵解,增加乳酸含量。Septin5高表达与p53含量和O-糖基化水平呈负相关。体内实验显示,甘露糖通过增加SEPT5表达促进ccRCC肿瘤生长。.综上所述,多组学分析发现ccRCC中特异性的甘露糖代谢重编程现象。低浓度甘露糖促进ccRCC发生发展,Septin5是关键分子。Septin5通过增强细胞增殖和迁移、侵袭能力影响ccRCC发展。Septin5与GFAT1相互作用抑制HBP途径,降低蛋白质O-糖基化水平,增强糖酵解。甘露糖促进SEPT5表达,逆转SEPT5敲低效应,降低p53蛋白O-糖基化水平,影响肿瘤功能,可能是ccRCC中甘露糖代谢重编程的分子机制。
转录因子ISL-1抑制正常成体胰岛β细胞凋亡的功能与分子机制研究
-
批准号:81660135
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2016
-
负责人:杨哲
-
依托单位:
国内基金
海外基金